Pesquisar
Climb Bio Inc
CLYMAdicionar à lista de desejos
11.900USD
-0.180-1.49%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
681.43MValor de mercado
PerdaP/L TTM
Mais detalhes de Climb Bio Inc Empresa
Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in a Phase Ib/IIa clinical trial. The Company is also developing CLYM116, an anti-APRIL antibody, in investigational new drug applications (IND)-enabling studies for IgA nephropathy (IgAN).
Informações de Climb Bio Inc
Código da empresaCLYM
Nome da EmpresaClimb Bio Inc
Data de listagemAug 10, 2021
CEOBrennan (Aoife M)
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 10
Endereço20 William Street
CidadeWELLESLEY HILLS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02481
Telefone18668572596
Sitehttps://climbbio.com/
Código da empresaCLYM
Data de listagemAug 10, 2021
CEOBrennan (Aoife M)
Executivos da empresa Climb Bio Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Aoife M. Brennan
Dr. Aoife M. Brennan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.98K
+44.02%
Dr. Andrew David Levin, M.D., Ph.D.
Dr. Andrew David Levin, M.D., Ph.D.
Director
Director
--
--
Dr. Judith A. Dunn, Ph.D.
Dr. Judith A. Dunn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Stephen Thomas, Ph.D.
Dr. Stephen Thomas, Ph.D.
Director
Director
--
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Alexander (Bo) Cumbo
Mr. Alexander (Bo) Cumbo
Independent Director
Independent Director
--
--
Dr. Douglas E. (Doug) Williams, Ph.D.
Dr. Douglas E. (Doug) Williams, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Cindy Driscoll
Ms. Cindy Driscoll
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Dr. Susan Altschuller, Ph.D.
Dr. Susan Altschuller, Ph.D.
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Aoife M. Brennan
Dr. Aoife M. Brennan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.98K
+44.02%
Dr. Andrew David Levin, M.D., Ph.D.
Dr. Andrew David Levin, M.D., Ph.D.
Director
Director
--
--
Dr. Judith A. Dunn, Ph.D.
Dr. Judith A. Dunn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Stephen Thomas, Ph.D.
Dr. Stephen Thomas, Ph.D.
Director
Director
--
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Alexander (Bo) Cumbo
Mr. Alexander (Bo) Cumbo
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Climb Bio Inc?
Os cinco principais acionistas de Climb Bio Inc são: Dr. Aoife M. Brennan
Quantas instituições possuem ações da Climb Bio Inc (CLYM)?
Em 2026Q1, 194 instituições possuíam ações da Climb Bio Inc, com valor de mercado aproximado de 35.98M, representando 59.67% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -6593711.00.